Bristol-Myers Squibb | Abatacept (Medication)
Abatacept is a soluble fusion protein that consists of the extracellular domain of human cytotoxic T-lymphocyte-associated antigen 4 (CTLA-4) linked to the modified Fc portion of human immunoglobulin G1. Abatacept is produced by recombinant DNA technology in a mammalian cell expression system. The apparent molecular weight of abatacept is 92 kilodaltons.
Abatacept lyophilized powder for intravenous infusion is supplied as a sterile, white, preservative-free, lyophilized powder for intravenous administration. ...
Side effects may occur, such as infection and cancer. headache and dizziness. upper respiratory tract infection and inflammation of nasopharynx. nausea. rash. cough, back pain, high blood pressure, indigestion, urinary tract infection and pain in legs.
Side effects in children:upper respiratory tract infection, inflammation of nasopharynx, headache, nausea, diarrhea, cough and abdominal pain. ...
Before using this medicine inform your doctor if you have any type of allergies. Tell your doctor if you are using other medicine and if you have or ever have had any of the following conditions:kidney disease, colitis, or stomach problems.
Abatacept can increase your chance of infections, including serious infections. You should not start the medication if you have an infection (even a skin infection). Abatacept can cause certain infections that have become inactive in the body (such as hepatitis B or tuberculosis) to become active again. These reactions include rashes, hives, itching, wheezing or difficulty breathing, and unusual swelling. Abatacept contains maltose, which can interfere with some blood glucose monitors.
During pregnancy and breastfeeding is not recommended to use this medicine without your doctor's advice. ...